Loading: 100%
EnteroMedics Inc logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter , , no data available
Employees 32 (as per Q2 2016)no data available
Sector Medical Devices, HealthcareMedical Devices, Healthcareno data available
Ticker ETRMno data available
Financial year endsFY ends End of Decemberno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 170,07,515,022,530,0
datesClosing price (adj.)
13.10.20171.94
11.10.20171.92
04.10.20172.06
27.09.20171.78
20.09.20171.84
13.09.20171.82
06.09.20171.80
30.08.20171.88
23.08.20171.89
16.08.20171.97
09.08.20173.26
02.08.20173.90
26.07.20174.62
19.07.20174.37
12.07.20174.42
05.07.20174.87
27.06.20175.06
20.06.20174.82
13.06.20175.05
06.06.20175.12
30.05.20175.07
23.05.20175.08
16.05.20174.38
09.05.20174.23
02.05.20174.17
25.04.20174.15
18.04.20175.47
11.04.20175.84
04.04.20175.92
28.03.20175.65
21.03.20175.84
14.03.20176.21
07.03.20176.40
28.02.20176.36
21.02.20176.64
14.02.20177.45
07.02.20177.34
31.01.20176.29
24.01.20177.47
17.01.20178.90
10.01.201727.70
03.01.20171.88
27.12.20162.90
19.12.20163.73
12.12.20164.55
05.12.20163.65
28.11.20164.99
21.11.20163.16
14.11.20164.28
07.11.20165.04
31.10.20165.82
24.10.20167.35
17.10.20166.72
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
1.94n/a
Market Capitalisation
in million USD
0n/a
Enterprise Value
in million USD
3n/a
Common Shares Outstanding
as per Jun 30, 2016
132,231n/a
Preferred Shares Outstanding
as per Jun 30, 2016
n/a
Average Basic Shares Outstanding
TTM
8,057,362n/a
Average Diluted Shares Outstanding
TTM
n/a
Index Membership
n/a
Business Summary
EnteroMedics Inc is a medical device company. The Company is focused on the design and development of devices which use neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders.
no data available
Key Financials & Ratios (all figures TTM as per Jun 30, 2016, million USD, full statements further below)
Profit & Loss
Revenues 1n/a
Gross Profit 0n/a
Operating Income -28n/a
EBITDA -28n/a
Net Profit -23n/a
Balance Sheet
Cash and Cash Equivalents 12n/a
Receivables 0n/a
Total Current Assets 14n/a
PP&E 0n/a
Total Assets 15n/a
Accounts Payable 0n/a
Current Debt 7n/a
Total Current Liabilities 10n/a
Long-Term Debt 8n/a
Total Liabilities 19n/a
Total Equity -4n/a
Cash Flow
Depreciation & Amortisation 0n/a
Change in Working Capital -1n/a
Operating Cash Flow -24n/a
Net Change in PP&E and Intangibles 0n/a
Investing Cash Flow 0n/a
Dividends Paid 0n/a
Financing Cash Flow 31n/a
Total Change in Cash 7n/a
Free Cash Flow -29n/a
Profitability Ratios
Gross Margin 48.4%n/a
Operating Margin -4,948.7%n/a
Net Profit Margin -4,157.7%n/a
Return on Equity 646.2%n/a
Return on Assets -155.6%n/a
Per Share Figures
Basic EPS -2.89n/a
Diluted EPS n/a
Sales per Share 0.07n/a
Book Value per Share -0.45n/a
FCF per Share -3.57n/a
Dividends per Share 0.00n/a
Price Multiples
Price to Earnings Ratio -0.67n/a
Price to Sales Ratio 27.86n/a
Price to Book Value -4.33n/a
Price to Free Cash Flow -0.54n/a
Valuation Metrics
EV/EBITDA -0.11n/a
EV/Sales 5.48n/a
Book to Market Value -14.07n/a
Other Ratios
Current Ratio 137.0%n/a
Liabilities to Equity Ratio -515.2%n/a
Debt to Assets Ratio 95.7%n/a
Profit & Loss StatementP&L data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13FY '14FY '15
Revenue
0
0
0
0
0
0
0
Sales & Services Revenue
0
0
0
0
0
0
0
Financing Revenue
0
0
0
0
0
0
0
Other Revenue
0
0
0
0
0
0
0
Cost of revenue
0
0
0
0
0
0
0
Cost of Goods & Services
0
0
0
0
0
0
0
Cost of Financing Revenue
0
0
0
0
0
0
0
Cost of Other Revenue
0
0
0
0
0
0
0
Gross Profit
0
0
0
0
0
0
0
Other Operating Income
0
0
0
0
0
0
0
Operating Expenses
-24
-16
-25
-23
-25
-26
-28
Selling, General & Administrative
-9
-8
-9
-12
-14
-15
-20
Selling & Marketing
0
0
0
0
0
0
0
General & Administrative
0
0
0
0
0
0
0
Research & Development
-16
-8
-17
-11
-11
-11
-8
Depreciation & Amortization
0
0
0
0
0
0
0
Provision For Doubtful Accounts
0
0
0
0
0
0
0
Other Operating Expense
0
0
0
0
0
0
0
Operating Income (Loss)
-24
-16
-25
-23
-25
-26
-28
Non-Operating Income (Loss)
-4
-1
-1
-1
-1
-1
-1
Interest Expense, net
-4
-1
-1
-1
-1
-1
-1
Interest Expense
0
0
0
0
0
0
0
Interest Income
0
0
0
0
0
0
0
Other Investment Income (Loss)
0
0
0
0
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
0
0
0
0
Income (Loss) from Affiliates
0
0
0
0
0
0
0
Other Non-Operating Income (Loss)
0
0
0
0
0
0
0
Pretax Income (Loss), Adjusted
-28
-18
-26
-23
-26
-26
-29
Abnormal Gains (Losses)
-4
0
0
0
0
0
3
Acquired In-Process R&D
0
0
0
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
0
0
0
Abnormal Derivatives
0
0
0
0
0
0
0
Disposal of Assets
0
0
0
0
0
0
0
Early extinguishment of Debt
0
0
0
0
0
0
0
Asset Write-Down
0
0
0
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
0
0
0
Sale of Business
0
0
0
0
0
0
0
Legal Settlement
0
0
0
0
0
0
0
Restructuring Charges
0
0
0
0
0
0
0
Sale of and Unrealized Investments
0
0
0
0
0
0
0
Insurance Settlement
0
0
0
0
0
0
0
Other Abnormal Items
0
0
0
0
0
0
0
Pretax Income (Loss)
-32
-17
-26
-23
-26
-26
-25
Income Tax (Expense) Benefit, net
0
0
0
0
0
0
0
Current Income Tax
0
0
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
0
0
Tax Allowance/Credit
0
0
0
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
0
0
0
Income (Loss) from Continuing Operations
-32
-17
-26
-23
-26
-26
-25
Net Extraordinary Gains (Losses)
0
0
0
0
0
0
0
Discontinued Operations
0
0
0
0
0
0
0
XO & Accounting Charges & Other
0
0
0
0
0
0
0
Income (Loss) Including Minority Interest
-32
-17
-26
-23
-26
-26
-25
Minority Interest
0
0
0
0
0
0
0
Net Income
-32
-17
-26
-23
-26
-26
-25
Preferred Dividends
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
Net Income Available to Common Shareholders
-32
-17
-26
-23
-26
-26
-25
Remarks
restated on Mar 15, 2012 n/a
calculated values,
restated on Mar 7, 2013 n/a
calculated values,
restated on Mar 27, 2014 n/a
calculated values,
restated on Mar 13, 2015 n/a
calculated values,
restated on Mar 28, 2016 n/a
calculated values,
restated on Mar 28, 2016 n/a
calculated values,
restated on Mar 28, 2016 n/a
calculated values,
Balance SheetBS data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13FY '14FY '15
Assets
Cash, Cash Equivalents & Short Term Investments
n/a
31
29
22
23
12
8
Cash & Cash Equivalents
n/a
31
28
22
23
12
8
Short Term Investments
n/a
0
1
0
0
0
0
Accounts & Notes Receivable
n/a
0
0
0
0
0
0
Accounts Receivable, Net
n/a
0
0
0
0
0
0
Notes Receivable, Net
n/a
0
0
0
0
0
0
Unbilled Revenues
n/a
0
0
0
0
0
0
Inventories
n/a
0
1
1
1
1
2
Raw Materials
n/a
0
0
0
0
0
0
Work In Process
n/a
0
0
0
0
0
0
Finished Goods
n/a
0
0
0
0
0
0
Other Inventory
n/a
0
0
0
0
0
0
Other Short Term Assets
n/a
7
1
1
1
0
1
Prepaid Expenses
n/a
0
1
1
1
0
1
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
Assets Held-for-Sale
n/a
0
0
0
0
0
0
Deferred Tax Assets
n/a
0
0
0
0
0
0
Income Taxes Receivable
n/a
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
Miscellaneous Short Term Assets
n/a
7
0
0
0
0
0
Total Current Assets
n/a
38
32
24
25
13
11
Property, Plant & Equipment, Net
n/a
1
1
1
1
0
0
Property, Plant & Equipment
n/a
0
0
0
0
0
0
Accumulated Depreciation
n/a
0
0
0
0
0
0
Long Term Investments & Receivables
n/a
0
0
0
0
0
0
Long Term Investments
n/a
0
0
0
0
0
0
Long Term Marketable Securities
n/a
0
0
0
0
0
0
Long Term Receivables
n/a
0
0
0
0
0
0
Other Long Term Assets
n/a
0
0
1
1
1
1
Intangible Assets
n/a
0
0
0
0
0
0
Goodwill
n/a
0
0
0
0
0
0
Other Intangible Assets
n/a
0
0
0
0
0
0
Prepaid Expense
n/a
0
0
0
0
0
0
Deferred Tax Assets
n/a
0
0
0
0
0
0
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
Prepaid Pension Costs
n/a
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
Investments in Affiliates
n/a
0
0
0
0
0
0
Miscellaneous Long Term Assets
n/a
0
0
1
1
1
1
Total Noncurrent Assets
n/a
1
1
2
1
1
1
Total Assets
n/a
39
32
26
26
14
12
Liabilities and owners' equity
Payables & Accruals
n/a
3 3075051
7 7256627
5 4537842
5 4840061
5 4745039
4 3768637
Accounts Payable
n/a
0 125188
0 434436
0 340555
0 127329
0 399336
0 172050
Accrued Taxes
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Interest & Dividends Payable
n/a
0 411492
0 448821
1 523678
1 526672
1 514937
0 1172
Other Payables & Accruals
n/a
3 2538371
6 6373370
4 3673609
4 4186060
4 3830766
4 3595415
Short Term Debt
n/a
1 921998
2 2307162
3 3000000
4 4000000
3 2976164
1 717391
Short Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Current Portion of Long Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Short Term Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Revenue
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Short Term Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Total Current Liabilities
n/a
4 3997049
10 9563789
8 7537842
9 8840061
8 7721203
4 4486028
Long Term Debt
n/a
5 4983159
3 2881161
7 6683972
3 2868330
0 0
1 549791
Long Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Long Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Long Term Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
3 2877817
Accrued Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Pension Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Pensions
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Post-Retirement Benefits
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Compensation
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Revenue
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
3 2877817
Total Noncurrent Liabilities
n/a
5 4983159
3 2881161
7 6683972
3 2868330
0 0
3 3427608
Total Liabilities
n/a
9 8980208
12 12444950
14 14221814
12 11708391
8 7721203
8 7913636
Preferred Equity
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Share Capital & Additional Paid-In Capital
n/a
180 180422044
197 196752522
212 212047083
241 240632448
259 258746186
281 281253987
Common Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Additional Paid in Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Share Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Treasury Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Retained Earnings
n/a
-151 -150714987
-177 -176712309
-200 -200172412
-226 -225953071
-252 -252081791
-278 -277580538
Other Equity
n/a
0 0
0 692
0 0
0 0
0 0
0 0
Equity Before Minority Interest
n/a
30 29707057
20 20040905
12 11874671
15 14679377
7 6664395
4 3673449
Minority Interest
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Total Equity
n/a
30 29707057
20 20040905
12 11874671
15 14679377
7 6664395
4 3673449
Total Liabilities & Equity
n/a
39 38687265
32 32485855
26 26096485
26 26387768
14 14385598
12 11587085
Remarks restated on n/a restated on Mar 15, 2012 n/a restated on Mar 7, 2013 n/a restated on Mar 27, 2014 n/a restated on Mar 13, 2015 n/a restated on Mar 28, 2016 n/a restated on Aug 12, 2016 n/a
Cash Flow StatementCF data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13FY '14FY '15
Net Income/Starting Line
-32
-17
-26
-23
-26
-26
-25
Net Income
0
0
0
0
0
0
0
Net Income From Discontinued Operations
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
Depreciation & Amortization
0
0
0
0
0
0
0
Non-Cash Items
8
3
3
4
6
6
4
Stock-Based Compensation
0
0
0
0
0
0
0
Deferred Income Taxes
0
0
0
0
0
0
0
Other Non-Cash Adjustments
0
0
0
0
0
0
0
Change in Working Capital
-1
0
3
-4
1
0
-2
(Increase) Decrease in Accounts Receivable
0
0
0
0
0
0
0
(Increase) Decrease in Inventories
0
0
0
0
0
0
0
Increase (Decrease) in Accounts Payable
0
0
0
0
0
0
0
Increase (Decrease) in Other
0
0
0
0
0
0
0
Net Cash From Discontinued Operations (operating)
0
0
0
0
0
0
0
Cash from Operating Activities
-25
-14
-20
-22
-18
-19
-23
Change in Fixed Assets & Intangibles
0
0
0
0
0
0
0
Disposition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
Disposition of Fixed Assets
0
0
0
0
0
0
0
Disposition of Intangible Assets
0
0
0
0
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
Purchase of Fixed Assets
0
0
0
0
0
0
0
Acquisition of Intangible Assets
0
0
0
0
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
0
0
0
0
Net Change in Long Term Investment
5
0
-1
1
0
0
0
Decrease in Long Term Investment
0
0
0
0
0
0
0
Increase in Long Term Investment
0
0
0
0
0
0
0
Net Cash From Acquisitions & Divestitures
0
0
0
0
0
0
0
Net Cash from Divestitures
0
0
0
0
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
0
0
0
0
Cash for Joint Ventures
0
0
0
0
0
0
0
Net Cash from Other Acquisitions
0
0
0
0
0
0
0
Other Investing Activities
0
-7
6
0
0
0
0
Net Cash From Discontinued Operations (investing)
0
0
0
0
0
0
0
Cash from Investing Activities
5
-7
5
1
0
0
0
Dividends Paid
0
0
0
0
0
0
0
Cash From (Repayment of) Debt
-7
4
-1
11
-3
-2
-2
Cash From (Repayment of) Short Term Debt, net
0
0
0
0
0
0
0
Cash From (Repayment of) Long Term Debt, net
0
0
0
0
0
0
0
Repayments of Long Term Debt
0
0
0
0
0
0
0
Cash From Long Term Debt
0
0
0
0
0
0
0
Cash From (Repurchase of) Equity
0
0
0
0
0
0
0
Increase in Capital Stock
0
0
0
0
0
0
0
Decrease in Capital Stock
0
0
0
0
0
0
0
Other Financing Activities
20
32
13
5
23
10
20
Net Cash From Discontinued Operations (financing)
0
0
0
0
0
0
0
Cash from Financing Activities
13
36
13
15
20
8
19
Net Cash Before Disc. Operations and FX
-6
16
-2
-6
1
-12
-4
Change in Cash from Disc. Operations and Other
0
0
0
0
0
0
0
Net Cash Before FX
-6
16
-2
-6
1
-12
-4
Effect of Foreign Exchange Rates
0
0
0
0
0
0
0
Net Changes in Cash
-6
16
-2
-6
1
-12
-4
Remarks
restated on Mar 15, 2012 n/a
calculated values,
restated on Mar 7, 2013 n/a
calculated values,
restated on Mar 27, 2014 n/a
calculated values,
restated on Mar 13, 2015 n/a
calculated values,
restated on Mar 28, 2016 n/a
calculated values,
restated on Mar 28, 2016 n/a
calculated values,
restated on Mar 28, 2016 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
Sumo